Oncoclinicas do Brasil (ONCO3) — Capital Reinvestment Ratio
Latest as of September 2025:
0.35x
Oncoclinicas do Brasil (ONCO3) has a Capital Reinvestment Ratio of 0.35x as of September 2025, meaning it reinvests 0% of its operating cash flow (R$151.75 Million) in capital expenditures (R$52.99 Million). See Oncoclinicas do Brasil (ONCO3) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.35x
Capex / Operating Cash Flow
Operating Cash Flow
R$151.75 Million
BRL
Capital Expenditures
R$52.99 Million
BRL
Data as of
Sep 2025
Most recent filing
Oncoclinicas do Brasil Capital Reinvestment Ratio (2013–2020)
This chart tracks Oncoclinicas do Brasil's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Oncoclinicas do Brasil (2013–2020)
Year-by-year Capital Reinvestment Ratio for Oncoclinicas do Brasil from 2013 to 2020. For live market cap and broader valuation context, see Oncoclinicas do Brasil market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.10x | R$97.56 Million | R$204.80 Million | ▲ +7.1% |
| 2019 | 1.96x | R$97.08 Million | R$190.19 Million | ▼ -68.1% |
| 2018 | 6.14x | R$38.86 Million | R$238.45 Million | ▲ +2296.1% |
| 2017 | 0.26x | R$135.26 Million | R$34.64 Million | ▼ -83.7% |
| 2014 | 1.57x | R$9.29 Million | R$14.57 Million | ▼ -30.5% |
| 2013 | 2.26x | R$7.34 Million | R$16.58 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow